Trial Profile
A six week double-blind, randomized, multicenter comparison study of the analgesic effectiveness of celecoxib 200 mg bid compared to tramadol hydrochloride 50 mg qid in subjects with chronic low back pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Tramadol
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 20 Oct 2009 Primary endpoint 'clinical response rate' has been met.
- 20 Oct 2009 Results presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals.
- 18 Nov 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.